-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Fortress Biotech, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2016 to 2024.
- Fortress Biotech, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2024 was $814 K, a 23.9% decline year-over-year.
- Fortress Biotech, Inc. annual Amortization of Intangible Assets for 2023 was $3.77 M, a 11.9% decline from 2022.
- Fortress Biotech, Inc. annual Amortization of Intangible Assets for 2022 was $4.28 M.
- Fortress Biotech, Inc. annual Amortization of Intangible Assets for 2020 was $1.42 M, a 21% increase from 2019.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)